Importantly, D2 antagonism in the hypothalamus may suppress HPA axis hyperactivity by reducing corticotropin-releasing hormone (CRH) secretion, thereby improving sleep continuity and reducing nocturnal awakenings, a key feature of depression-related sleep disturbances (9, 30). Here, CRH is linked to depressive symptom measurement.